NCT06676735

Brief Summary

With the support of partial dual temperature monitoring (comparing the specific difference between standardized axillary temperature monitoring and esophageal temperature), this trial is divided into the following three parts:

  1. 1.Multi center observational study: Establish and validate a dynamic incremental training intraoperative hypothermia prediction model - Intelligent Care for the Elderly (ICE) - Intraoperative hypothermia warning system, and provide ICE Offline for use by healthcare professionals and ICE Online for further model updates when needed for clinical or research purposes.
  2. 2.Multi center non randomized controlled clinical trial: Conduct a multi center stratified temperature management clinical trial based on ICE Offline after dynamic incremental training to verify the clinical and economic benefits of the model and active warming.
  3. 3.Pre and post comparative study: Collect data before ICE application and compare it with data after ICE promotion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,323

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 6, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

March 11, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2026

Completed
Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

October 31, 2024

Last Update Submit

January 14, 2026

Conditions

Keywords

Intraoperative hypothermiaPrediction modelElderly patientsActive warmingMachine Learning

Outcome Measures

Primary Outcomes (1)

  • Intraoperative hypothermia

    Intraoperative hypothermia, defined as a core temperature below 36 °C

    Up to 24 hours, from the time of entry into the operating room to the time of exit from the operating room.

Secondary Outcomes (16)

  • The specificity and sensitivity of the model

    1 year

  • Physical sensation

    Perioperative period

  • Total volume of intraoperative blood loss

    Intraoperative

  • Postoperative shivering

    Up to 60 minutes

  • Postoperative coagulation index

    Within 24 hours after operation

  • +11 more secondary outcomes

Study Arms (4)

Intraoperative hypothermia low risk group

EXPERIMENTAL

Patients included this group are determined by prediction model. Operating room environment temperature was set at not less than 21°C, with a relative humidity of 50% to 60%. Patients are covered from neck to feet with a cotton blanket and the area to be disinfected and operated on is uncovered after induction of anesthesia. All patients will be administered intravenous fluid warmers and irrigation fluid prewarming (37℃\~43℃).

Diagnostic Test: Prediction of intraoperative hypothermia riskOther: Measurement of tympanic membrane temperature

Intraoperative hypothermia high risk group

EXPERIMENTAL

Patients included this group are determined by prediction model. In addition to the measures taken in intraoperative hypothermia low risk group, an inflatable warming system, including a forced air warming system and forced air warming blanket, is employed for prewarming before anesthesia initiation and for maintaining body temperature throughout the operation. During the surgery, the insulation blanket will be applied to non surgical areas, and the host temperature will be adjusted to 38 ℃ for warming. If the temperature of the patient is lower than 36 ℃, the temperature of the system can be adjusted to 43 ℃; if the temperature of the patient is higher than 37 ℃, the temperature of the system can be adjusted to 32 ℃. After the patient's temperature is normal, it can be adjusted back to 38 ℃.

Device: Inflatable warming systemDiagnostic Test: Prediction of intraoperative hypothermia riskOther: Measurement of tympanic membrane temperature

Model optimization group

OTHER

Only observe the patient's baseline, intraoperative hypothermia, postoperative complications, and other indicators, and collect data through the electronic Data Capture System to optimize existing intraoperative hypothermia prediction model. The estimated sample size is 600 cases by the incremental learning curve calculating.

Other: The difference between axillary temperatature and core temperature in elderly patientsOther: Measurement of tympanic membrane temperature

Group of model benefit evaluation

NO INTERVENTION

Data of this group is medical records before the application of the intraoperative hypothermia prediction model, which will be collected from the electronic medical record system.

Interventions

Inflatable warming system, including a forced air warming system (IOB, WU505) and forced air warming blanket (IOB-001, IOB-006, IOB-011), is employed for prewarming before anesthesia initiation and for maintaining body temperature throughout the operation. During the surgery, the insulation blanket will be applied to non surgical areas, and the host temperature will be adjusted to 38 ℃ for warming. If the temperature of the patient is lower than 36 ℃, the temperature of the system can be adjusted to 43 ℃; if the temperature of the patient is higher than 37 ℃, the temperature of the system can be adjusted to 32 ℃. After the patient\'s temperature is normal, it can be adjusted back to 38 ℃.

Intraoperative hypothermia high risk group

According to the Intelligent Care For The Elderly (ICE, an optimized model based on the existing prediction model of our research group after dynamic incremental training), patients are divided into intraoperative hypothermia lowrisk group and intraoperative hypothermia high risk group.

Intraoperative hypothermia high risk groupIntraoperative hypothermia low risk group

Previous studies have shown that the difference and standard deviation between esophageal temperature and axillary temperature are core 0.05 ℃ and 0.26 ℃, respectively. In light of 10% dropout rate, a integer sample size of 400 achieves 95% power to detect a mean of paired differences of 0.05 with an estimated standard deviation of paired differences of 0.26 and with a significance level (alpha) of 0.05 using a two-sided paired t-test. So 400 patients in the Model optimization group need to undergo core temperature (esophageal temperature or nasopharyngeal temperature).

Model optimization group

As a intraoperative core temperature reference (measure every 15 minutes) for patients without esophageal temperature or nasopharyngeal temperature monitoring.

Intraoperative hypothermia high risk groupIntraoperative hypothermia low risk groupModel optimization group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elderly patients (aged 60 and above) undergoing non cardiac elective surgery under general anesthesia;
  • minutes ≤ Estimated surgical duration ≤ 240 minutes ;
  • Normal preoperative bleeding and clotting time
  • American society of Aneshesiologists physical status classification system:Ⅰ~Ⅳ

You may not qualify if:

  • Mental illness
  • Cirrhosis
  • Existence or potential central hyperthermia
  • Metabolic thermoregulatory abnormalities
  • History of malignant hyperthermia or family history
  • Extensive skin burns or injuries
  • Seriously infect
  • Long term use of nonsteroidal anti-inflammatory drugs
  • Expected difficult airway
  • Researchers believe that individuals who are not suitable to participate in clinical trial
  • Refusal to sign informed consent form
  • Withdraw informed consent form
  • Severe bleeding or shock during perioperative period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400010, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

October 31, 2024

First Posted

November 6, 2024

Study Start

March 11, 2025

Primary Completion

December 15, 2025

Study Completion

January 14, 2026

Last Updated

January 16, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Data Data available: Yes Data types: Identified participant data How to access data: atpcr7@yeah.net When available: Within 5years after this trial Supporting Documents Document types: None Additional Information Who can access the data: Researchers whose proposed use of the data have been approved by Leader Sponsor and Principal Investigator of this trial. Types of analyses: To be discussed with the steering committee. Mechanisms of data availability: With investigator support after approval signed data access agreement. Any additional restrictions: None

Shared Documents
STUDY PROTOCOL, SAP, CSR

Locations